In glioblastoma cells, EGF treatment promotes GDH1 expression through the MEK/ERK/ELK1 pathway, stimulating glutaminolysis and incorporation of glutamine carbons into TCA cycle intermediates (Yang et al., 2020). This evidence concerns the gene EGF and glioblastoma.